HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

HENGRUI PHARMA

48.000

-0.440-0.91%

Volume:7.08M

Turnover:338.60M

Market Cap:318.58B

PE:34.69

High:49.100

Open:48.980

Low:46.480

Close:48.440

52wk High:88.043

52wk Low:43.020

Shares:6.64B

HK Float Shares:258.00M

Volume Ratio:1.86

T/O Rate:2.75%

Dividend:0.23

Dividend Rate:0.49%

EPS(LYR):1.384

ROE:12.46%

ROA:7.02%

PB:4.21

PE(LYR):34.69

PS:8.67

Loading ...

Overview Company News Filings

Movement Alert｜HENGRUI PHARMA Falls 3.01% in Regular Trading, Pharmaceuticals Sector Under Broad Selling Pressure

HENGRUI PHARMA Spends RMB 11.37 Million Buying Back 250,000 A-Shares on September 23

Jiangsu Hengrui Pharmaceuticals Secures Clinical Trial Approvals for Ten Drug Candidates

Hengrui Pharma Gets Clinical Trial Approval for Chronic Kidney Disease Drug

MT Newswires Live

Hengrui Pharmaceuticals Gets China Approval for Tumor Drug Trial

MT Newswires Live

Hengrui Pharma's Unit Gets Nod to Trial HRS-1596 Tablets; Shares Down 3%

MT Newswires Live

Movement Alert｜HENGRUI PHARMA Falls 3.04% in Regular Trading, Pulling Back After Prior Sessions Strong Rally Amid Broad Sector Weakness

Jiangsu Hengrui Pharmaceuticals Secures Clinical Trial Approval for SHR-4595 Injection

Citi Highlights Policy Boost for Innovative Drugs and Medical Devices, Names Key Sector Picks

Movement Alert｜HENGRUI PHARMA Rises 3.11% in Regular Trading, Buyback Launched and Employee Stock Plan Unveiled Amid BlackRock Accumulation

HENGRUI PHARMA: BlackRock, Inc. Disposes, Long Position Falls to 6.99%

Hong Kong Stock Market Update | Hengrui Pharma Surges Nearly 4% on First A-Share Buyback as Analysts Eye Growth in Non-Oncology Portfolio

Movement Alert｜HENGRUI PHARMA Rises 3.78% in Regular Trading, First A-Share Buyback Executed as BlackRock Raises Stake to 7.68%

Blackrock's Long Position in H-Shares of Jiangsu Hengrui Pharmaceuticals Increases to 7.68% on Sept 14, HKEX Filing Shows

Hengrui Pharma Repurchases 335,000 A-Shares for ESOP at RMB 43.29 Each, Equal to 0.005% of Issued Capital

Bulletin Express

Jiangsu Hengrui Pharmaceuticals Completes Initial Share Repurchase, Investing 14.5 Million Yuan

HENGRUI PHARMA: BlackRock, Inc. Acquires Shares, Long Position Rises to 7.68%

Hong Kong Stock Market Update: Hengrui Pharma Surges Nearly 4% in Late Trading Following Dual Clinical Trial Approvals

China's Jiangsu Hengrui Climbs on Clinical Trial Approval for Stroke Drug

Hengrui Pharmaceuticals' Unit Gets Nod to Trial Recaticimab Injection

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au.etasphere.com/stock/01276/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"01276","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01276\",,,,,undefined,":{"symbol":"01276","market":"HK","secType":"STK","nameCN":"HENGRUI PHARMA","latestPrice":48,"timestamp":1791533288000,"preClose":48.44,"halted":0,"volume":7084600,"delay":0,"changeRate":-0.009083402146985916,"floatShares":258000000,"shares":6637000000,"eps":1.3837561316349194,"marketStatus":"Market Closed","change":-0.44,"latestTime":"10-09 16:08:08","open":48.98,"high":49.1,"low":46.48,"amount":338603291,"amplitude":0.054088,"askPrice":48,"askSize":1600,"bidPrice":47.98,"bidSize":800,"shortable":3,"etf":0,"ttmEps":1.364629807476474,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791768600000},"marketStatusCode":7,"adr":0,"listingDate":1747929600000,"exchange":"SEHK","adjPreClose":48.44,"dividendRate":0.004874,"openAndCloseTimeList":[[1791509400000,1791518400000],[1791522000000,1791532800000]],"volumeRatio":1.8649424306576454,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"600276","market":"SH","secType":"STK","nameCN":"Jiangsu Hengrui Pharmaceuticals Co.,Ltd.","latestPrice":46.85,"timestamp":1791529200000,"preClose":47.01,"halted":0,"volume":62812700,"delay":0,"premium":"-12.63"}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01276\",,,,,undefined,":{"symbol":"01276","floatShares":258000000,"roa":"7.02%","roe":"12.46%","lyrEps":1.383756,"volumeRatio":1.8649424306576454,"shares":6637000000,"dividePrice":0.234535,"high":49.1,"amplitude":0.054088,"preClose":48.44,"low":46.48,"week52Low":43.02,"pbRate":"4.21","psRate":"8.67","week52High":88.043,"institutionHeld":0,"latestPrice":48,"committee":-0.333333,"eps":1.3837561316349194,"divideRate":0.004886,"volume":7084600,"delay":0,"ttmEps":1.364629807476474,"open":48.98,"prevYearClose":71.002,"prevWeekClose":49.66,"prevMonthClose":50.2,"prevQuarterClose":50.2,"fiveDayClose":49.66,"twentyDayClose":43.96,"sixtyDayClose":57.95,"earningDate":1793116800000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01276\",params:#limit:5,,,undefined,":[{"date":"2026-10-28","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1793151000000,"name":null,"time":"","dateTimestamp":1793116800000,"actualEps":null},{"date":"2026-08-19","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787103000000,"name":null,"time":"","dateTimestamp":1787068800000,"actualEps":null},{"date":"2026-04-29","symbol":"01276","amount":0.22828,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2026-04-30","defaultRemindTime":1777426200000,"name":"恒瑞医药","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-05-27","payableDate":"2026-04-30","currency":"HKD","dateTimestamp":1777392000000,"payDate":"2026-05-27"},{"date":"2026-04-22","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1776821400000,"name":null,"time":"","dateTimestamp":1776787200000,"actualEps":null},{"date":"2026-03-26","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774488600000,"name":null,"time":"","dateTimestamp":1774454400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01276\",market:\"HK\",,,undefined,":[{"executeDate":"2026-04-29","recordDate":"2026-04-30","paymentDate":"2026-05-27","value":0.22828,"currency":"HKD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01276\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.2727,"buy":0.5455,"hold":0.1818,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5455,"analysts":11,"updateTime":1786723200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01276\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01276","date":"2026-10-09","current":35.174375,"percent":0.119883,"low":36.382401,"twenty":42.857544,"median":51.138757,"eighty":56.781666,"high":65.582363,"avg":50.516449,"sd":7.729997,"marketCap":361173641492.57},"quantilePoints":[{"date":"2025-05-23","current":52.570963,"twenty":52.783176,"median":53.101495,"eighty":53.419815,"marketCap":390693388207.53},{"date":"2025-05-30","current":53.015805,"twenty":51.822085,"median":52.540895,"eighty":52.926837,"marketCap":395731540422.24},{"date":"2025-06-06","current":52.120101,"twenty":52.130014,"median":52.555929,"eighty":53.075252,"marketCap":390038198012.59},{"date":"2025-06-13","current":52.209491,"twenty":52.177631,"median":52.691227,"eighty":53.357137,"marketCap":390861633032.23},{"date":"2025-06-20","current":50.172412,"twenty":51.591196,"median":52.469796,"eighty":53.075252,"marketCap":374874997562.85},{"date":"2025-06-27","current":50.314776,"twenty":50.363569,"median":52.169666,"eighty":53.013533,"marketCap":376991477472.78},{"date":"2025-07-04","current":51.666141,"twenty":50.343584,"median":52.120101,"eighty":53.004446,"marketCap":387134991658.26},{"date":"2025-07-11","current":55.507007,"twenty":50.44351,"median":52.13337,"eighty":53.090114,"marketCap":415495681161.23},{"date":"2025-07-18","current":57.272274,"twenty":50.582121,"median":52.209491,"eighty":54.057606,"marketCap":428373566715.29},{"date":"2025-07-25","current":54.897923,"twenty":50.594414,"median":52.555929,"eighty":55.711415,"marketCap":412107620053.2},{"date":"2025-08-01","current":59.731878,"twenty":50.855059,"median":52.994419,"eighty":55.972407,"marketCap":445624526286.47},{"date":"2025-08-08","current":59.478715,"twenty":51.107295,"median":53.05296,"eighty":56.541585,"marketCap":444845815775.64},{"date":"2025-08-15","current":61.917611,"twenty":51.356483,"median":53.519848,"eighty":59.478715,"marketCap":462392609292.46},{"date":"2025-08-22","current":58.782188,"twenty":51.569512,"median":54.477764,"eighty":60.15932,"marketCap":470428104569.66},{"date":"2025-08-29","current":59.85298,"twenty":51.666141,"median":55.691374,"eighty":59.937003,"marketCap":481284287403.35},{"date":"2025-09-05","current":65.582363,"twenty":51.677932,"median":55.770266,"eighty":60.732448,"marketCap":526832269752.24},{"date":"2025-09-12","current":62.481332,"twenty":51.8337,"median":55.972407,"eighty":61.285609,"marketCap":502824785657.99},{"date":"2025-09-19","current":63.179889,"twenty":52.120101,"median":56.254853,"eighty":61.852995,"marketCap":508085671393.42},{"date":"2025-09-26","current":63.528382,"twenty":52.146639,"median":56.965096,"eighty":62.270337,"marketCap":509562668601.01},{"date":"2025-10-03","current":64.989073,"twenty":52.165061,"median":57.272274,"eighty":62.504861,"marketCap":522523002865.02},{"date":"2025-10-10","current":61.782766,"twenty":52.193561,"median":59.039802,"eighty":62.657943,"marketCap":496019912951.91},{"date":"2025-10-17","current":58.903713,"twenty":52.323014,"median":59.170669,"eighty":62.619084,"marketCap":472537436949.31},{"date":"2025-10-24","current":59.187086,"twenty":52.484015,"median":59.039802,"eighty":62.52839,"marketCap":474983377696.11},{"date":"2025-10-31","current":57.072441,"twenty":52.552922,"median":59.021138,"eighty":62.417499,"marketCap":465758305542.93},{"date":"2025-11-07","current":54.713071,"twenty":52.619069,"median":58.881843,"eighty":62.304573,"marketCap":446224987036.64},{"date":"2025-11-14","current":55.883072,"twenty":52.812504,"median":58.231971,"eighty":62.27542,"marketCap":457058673340.29},{"date":"2025-11-21","current":52.805265,"twenty":52.880927,"median":57.030538,"eighty":62.209511,"marketCap":431684582485.14},{"date":"2025-11-28","current":55.237621,"twenty":52.99843,"median":56.630614,"eighty":62.069705,"marketCap":453209419829.34},{"date":"2025-12-05","current":54.841023,"twenty":53.00899,"median":56.437545,"eighty":61.965159,"marketCap":450729029423.46},{"date":"2025-12-12","current":56.212257,"twenty":53.045529,"median":56.385682,"eighty":61.891765,"marketCap":462853512587.19},{"date":"2025-12-19","current":54.083493,"twenty":53.045529,"median":56.227363,"eighty":61.831221,"marketCap":446374731108.34},{"date":"2025-12-24","current":54.414957,"twenty":53.090114,"median":56.103073,"eighty":61.798561,"marketCap":450509359276.9},{"date":"2026-01-02","current":53.078544,"twenty":53.065996,"median":55.972407,"eighty":61.785925,"marketCap":441174507319.22},{"date":"2026-01-09","current":56.743223,"twenty":53.0878,"median":56.0944,"eighty":61.695241,"marketCap":472808676524.34},{"date":"2026-01-16","current":55.187351,"twenty":53.304215,"median":56.103073,"eighty":61.405393,"marketCap":461338821289.95},{"date":"2026-01-23","current":52.546341,"twenty":53.0878,"median":56.076447,"eighty":61.296167,"marketCap":438839874056.97},{"date":"2026-01-30","current":51.677141,"twenty":52.994149,"median":55.908509,"eighty":61.278475,"marketCap":433553740508.2},{"date":"2026-02-06","current":50.918226,"twenty":52.680723,"median":55.839154,"eighty":61.101743,"marketCap":428270226283.58},{"date":"2026-02-13","current":51.771686,"twenty":52.512455,"median":55.711415,"eighty":60.890064,"marketCap":437949787160.49},{"date":"2026-02-20","current":51.752043,"twenty":52.351169,"median":55.691374,"eighty":60.824953,"marketCap":437153052005.04},{"date":"2026-02-27","current":50.215456,"twenty":52.151244,"median":55.507566,"eighty":60.720339,"marketCap":428825318404.97},{"date":"2026-03-06","current":49.335298,"twenty":51.80347,"median":55.280584,"eighty":60.654676,"marketCap":417912584744.19},{"date":"2026-03-13","current":48.90444,"twenty":51.75217,"median":55.201025,"eighty":60.572606,"marketCap":416170839186.33},{"date":"2026-03-20","current":48.948437,"twenty":51.671435,"median":55.086674,"eighty":60.515374,"marketCap":414967977646.95},{"date":"2026-03-27","current":47.483832,"twenty":51.400677,"median":54.94883,"eighty":60.443129,"marketCap":414588875872.42},{"date":"2026-04-02","current":49.302243,"twenty":51.107295,"median":54.905743,"eighty":60.227005,"marketCap":432534434303.11},{"date":"2026-04-10","current":49.055344,"twenty":50.995993,"median":54.897923,"eighty":60.186394,"marketCap":433687668394.36},{"date":"2026-04-17","current":48.417764,"twenty":50.589497,"median":54.65026,"eighty":60.143018,"marketCap":428230701835.75},{"date":"2026-04-24","current":45.835792,"twenty":50.342877,"median":54.475147,"eighty":60.015062,"marketCap":426879682872.04},{"date":"2026-04-30","current":44.026312,"twenty":50.285416,"median":54.355253,"eighty":59.903394,"marketCap":410132737659.64},{"date":"2026-05-08","current":43.161515,"twenty":50.207478,"median":54.262074,"eighty":59.804539,"marketCap":403472171949.3},{"date":"2026-05-15","current":44.128138,"twenty":49.985706,"median":54.115335,"eighty":59.70386,"marketCap":413593092820.6},{"date":"2026-05-22","current":41.244553,"twenty":49.583265,"median":53.983854,"eighty":59.631568,"marketCap":385683097978.4},{"date":"2026-05-29","current":40.98659,"twenty":49.34142,"median":53.840414,"eighty":59.564678,"marketCap":384603594259.51},{"date":"2026-06-05","current":38.394132,"twenty":49.063316,"median":53.633194,"eighty":59.459458,"marketCap":360799766229.36},{"date":"2026-06-12","current":39.515262,"twenty":48.81081,"median":53.517715,"eighty":59.36625,"marketCap":371084155232.86},{"date":"2026-06-18","current":39.444808,"twenty":48.417764,"median":53.467699,"eighty":59.301536,"marketCap":371311256576.18},{"date":"2026-06-26","current":39.60241,"twenty":47.951326,"median":53.090114,"eighty":59.187086,"marketCap":370974287810.31},{"date":"2026-07-03","current":44.319925,"twenty":47.638943,"median":53.015805,"eighty":59.069259,"marketCap":415476044901.86},{"date":"2026-07-10","current":45.319748,"twenty":47.348429,"median":52.993744,"eighty":59.024871,"marketCap":424327469311.14},{"date":"2026-07-17","current":43.189222,"twenty":46.151454,"median":52.805265,"eighty":58.96135,"marketCap":405818502739.33},{"date":"2026-07-24","current":43.433009,"twenty":45.632553,"median":52.604835,"eighty":58.912251,"marketCap":408200902707.63},{"date":"2026-07-31","current":43.935338,"twenty":45.29749,"median":52.543618,"eighty":58.877468,"marketCap":413706414238.87},{"date":"2026-08-07","current":44.394532,"twenty":45.008473,"median":52.339287,"eighty":58.813302,"marketCap":418841988303.56},{"date":"2026-08-14","current":42.6704,"twenty":44.628794,"median":52.189578,"eighty":58.452058,"marketCap":403085247281.44},{"date":"2026-08-21","current":40.686911,"twenty":44.408765,"median":52.120101,"eighty":57.75211,"marketCap":366558497066.13},{"date":"2026-08-28","current":40.334802,"twenty":44.24321,"median":51.814807,"eighty":57.336246,"marketCap":363468645736.13},{"date":"2026-09-04","current":39.220129,"twenty":44.050964,"median":51.771686,"eighty":57.152374,"marketCap":353565883607.49},{"date":"2026-09-11","current":36.382401,"twenty":43.912617,"median":51.717719,"eighty":57.022157,"marketCap":328426636361.34},{"date":"2026-09-18","current":37.472943,"twenty":43.707258,"median":51.677141,"eighty":56.974512,"marketCap":338713028678.65},{"date":"2026-09-25","current":38.226655,"twenty":43.43262,"median":51.617827,"eighty":56.891919,"marketCap":344867204477.93},{"date":"2026-10-02","current":40.279147,"twenty":43.172598,"median":51.438629,"eighty":56.828798,"marketCap":363767175425.28},{"date":"2026-10-09","current":39.942129,"twenty":42.857544,"median":51.138757,"eighty":56.781666,"marketCap":361173641492.57}],"updateTime":1791669796213},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01276\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1137502049","title":"Movement Alert｜HENGRUI PHARMA Falls 3.01% in Regular Trading, Pharmaceuticals Sector Under Broad Selling Pressure","url":"https://stock-news.laohu8.com/highlight/detail?id=1137502049","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137502049?lang=en_us&edition=fundamental","pubTime":"2026-09-24 10:27","pubTimestamp":1790216820,"startTime":"0","endTime":"0","summary":"On September 24, HENGRUI PHARMA fell 3.01% in regular trading, trading at HK$45.80/share, with turnover of approximately HK$37.63 million.The decline was primarily driven by broad-based weakness...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Hengrui Pharma Slips as Sector Selloff Hits Drug Stocks","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165450532","title":"HENGRUI PHARMA Spends RMB 11.37 Million Buying Back 250,000 A-Shares on September 23","url":"https://stock-news.laohu8.com/highlight/detail?id=1165450532","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165450532?lang=en_us&edition=fundamental","pubTime":"2026-09-23 17:45","pubTimestamp":1790156710,"startTime":"0","endTime":"0","summary":"On September 23, 2026, HENGRUI PHARMA (01276) executed a share repurchase, investing RMB 11.3723 million to buy back 250,000 A-shares. The buyback price ranged between RMB 45.42 and RMB 45.54 per...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2097828805.USD","LU1023057109.AUD","LU0359201885.HKD","LU1328615791.USD","LU2097828714.EUR","LU2580892862.HKD","BK1191","LU1580142542.USD","LU2328871848.SGD","03188","BK0060","BK0183","07233","LU1820825898.SGD","LU1064130708.USD","LU1969619763.USD","LU1064131003.USD","02827","BK1147","600276","LU2097828557.USD","399300","LU2148510915.USD","LU2495084118.USD","02846","BK0012","LU2097828474.EUR","01276","BK0196","LU1997245177.USD","LU0405327148.USD","LU1997245094.SGD","03130","LU0405327494.USD","LU0359202008.SGD","LU2289578879.USD","BK0028","83130","BK0188","LU1146622755.USD","159982","LU1655091616.SGD","LU1997244956.HKD","LU2488822045.USD","LU2543165471.USD","BK0239","LU0359201612.USD","LU2580892789.USD","83188","LU1255011170.USD","LU1781817850.SGD","LU2097828631.EUR","82846"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112810908","title":"Jiangsu Hengrui Pharmaceuticals Secures Clinical Trial Approvals for Ten Drug Candidates","url":"https://stock-news.laohu8.com/highlight/detail?id=1112810908","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112810908?lang=en_us&edition=fundamental","pubTime":"2026-09-23 16:42","pubTimestamp":1790152956,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co.,Ltd. (600276.SH) has announced that it and its subsidiaries recently received Drug Clinical Trial Approval Notices from the National Medical Products...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2097828557.USD","LU2148510915.USD","LU2580892789.USD","LU0359201612.USD","LU1023057109.AUD","LU2488822045.USD","PSYK","LU2097828631.EUR","LU1064130708.USD","LU1997245177.USD","LU1820825898.SGD","LU2097828714.EUR","LU1997244956.HKD","LU2097828805.USD","MDTX","BK0028","LU2328871848.SGD","LU0359201885.HKD","LU1328615791.USD","LU1655091616.SGD","BK0239","LU0405327148.USD","LU0405327494.USD","IBBJ","LU2097828474.EUR","LU1064131003.USD","IBBQ","LU1146622755.USD","BK0183","BMED","LU0359202008.SGD","LU1580142542.USD","BK0196","LU2580892862.HKD","BK0012","LU2495084118.USD","LU1969619763.USD","LU2543165471.USD","LU1997245094.SGD","BK0060","LU1781817850.SGD","BK1191","01276","LU1255011170.USD","600276","BK0188","LU2289578879.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669190516","title":"Hengrui Pharma Gets Clinical Trial Approval for Chronic Kidney Disease Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2669190516","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669190516?lang=en_us&edition=fundamental","pubTime":"2026-09-22 10:58","pubTimestamp":1790045905,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals  and its subsidiary Fujian Shengdi Medicine received clinical trial approval from China's National Medical Products Administration for its HRS-4729 self-developed injection for chronic kidney disease.The drug suppresses appetite, delays gastric emptying, improves insulin sensitivity, breaks down fat, and boosts energy expenditure, according to a Tuesday filing with the Shanghai bourse.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0359201612.USD","LU0359202008.SGD","BK1191","LU2543165471.USD","01276","LU1023057109.AUD","LU0359201885.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669190378","title":"Hengrui Pharmaceuticals Gets China Approval for Tumor Drug Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2669190378","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669190378?lang=en_us&edition=fundamental","pubTime":"2026-09-22 10:52","pubTimestamp":1790045534,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals  unit Suzhou Shengdia Biopharmaceutical obtained China's regulatory approval to conduct clinical trials for SHR-4595 injection.The trial will evaluate the biological product's efficacy in treating patients with advanced malignant solid tumors, according to a Monday aftermarket filing with the Shanghai bourse.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2543165471.USD","BK1191","LU1023057109.AUD","LU0359201612.USD","01276","LU0359202008.SGD","LU0359201885.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669197087","title":"Hengrui Pharma's Unit Gets Nod to Trial HRS-1596 Tablets; Shares Down 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669197087","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669197087?lang=en_us&edition=fundamental","pubTime":"2026-09-22 10:40","pubTimestamp":1790044833,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals'  unit, Fujian Shengdi Pharmaceutical, received approval from China's National Medical Products Administration to conduct clinical trials on HRS-1596 tablets, according to a Tuesday disclosure on the Shanghai bourse.The drug will be tested as a weight management product and as a treatment for type 2 diabetes mellitus.The pharmaceutical company's Hong Kong shares fell 3% and Shanghai shares slipped 1% during the morning trade.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["01276","LU1023057109.AUD","LU0359201885.HKD","LU2543165471.USD","LU0359201612.USD","LU0359202008.SGD","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162211536","title":"Movement Alert｜HENGRUI PHARMA Falls 3.04% in Regular Trading, Pulling Back After Prior Sessions Strong Rally Amid Broad Sector Weakness","url":"https://stock-news.laohu8.com/highlight/detail?id=1162211536","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162211536?lang=en_us&edition=fundamental","pubTime":"2026-09-22 09:57","pubTimestamp":1790042227,"startTime":"0","endTime":"0","summary":"On September 22, HENGRUI PHARMA declined 3.04% in regular trading, trading at HK$48.0/share, with turnover of HK$60.72 million. The pullback follows a sharp rally of over 6% in the prior session,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Hengrui Pharma Falls as Citi, BofA Rally Fades","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174623645","title":"Jiangsu Hengrui Pharmaceuticals Secures Clinical Trial Approval for SHR-4595 Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=1174623645","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174623645?lang=en_us&edition=fundamental","pubTime":"2026-09-21 16:56","pubTimestamp":1789980976,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co.,Ltd. (SH: 600276) has announced that its subsidiary, Suzhou Sdiary Biopharmaceuticals Co., Ltd., recently obtained the Clinical Trial Approval Notice for the...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0359201885.HKD","LU1781817850.SGD","LU2148510915.USD","LU0359202008.SGD","LU2097828631.EUR","BK0239","LU0359201612.USD","LU1328615791.USD","LU2328871848.SGD","LU1969619763.USD","LU2097828474.EUR","01276","IBBQ","BK0060","LU1997245094.SGD","BK1191","LU1820825898.SGD","LU2580892862.HKD","BK0183","BMED","IBBJ","BK0028","LU1023057109.AUD","LU2543165471.USD","LU2495084118.USD","LU1997244956.HKD","LU1655091616.SGD","LU0405327494.USD","BK0012","LU1146622755.USD","LU2289578879.USD","LU1997245177.USD","600276","LU1064131003.USD","LU1580142542.USD","LU0405327148.USD","LU1064130708.USD","LU1255011170.USD","LU2097828714.EUR","LU2097828805.USD","LU2580892789.USD","LU2488822045.USD","BK0196","PSYK","MDTX","LU2097828557.USD","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112501840","title":"Citi Highlights Policy Boost for Innovative Drugs and Medical Devices, Names Key Sector Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=1112501840","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112501840?lang=en_us&edition=fundamental","pubTime":"2026-09-21 15:17","pubTimestamp":1789975044,"startTime":"0","endTime":"0","summary":"Citi has issued a research report following the joint release of the 15th Five-Year Plan for the Pharmaceutical Industry Development by the Ministry of Industry and Information Technology and other...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","BK1521","IE0008368742.USD","IE00B543WZ88.USD","BK4559","LU0029874905.USD","AGNG","LU0320765646.SGD","159992","LU1226287875.USD","LU0880133367.SGD","IBBQ","BK1141","LU0980610538.SGD","LU1688375341.USD","LU1152091754.HKD","LU1144417596.USD","LU1813983027.USD","LU1267930227.SGD","BK1100","IE00BZ08YT58.USD","LU0196878994.USD","LU0149534421.HKD","LU0244354667.USD","BK1576","LU0819121731.USD","LU0823426308.USD","LU0315179316.USD","LU2125154778.USD","LU2097828557.USD","LU2543165471.USD","LU0572944931.SGD","LU0098860793.USD","LU1831875114.USD","BK4504","LU1244550577.SGD","BK1161","IYF","LU0588546209.SGD","LU0029874061.USD","LU1242518857.USD","BK1583","LU1791807156.HKD","LU0162691827.USD","LU0516423091.SGD","LU0359202008.SGD","LU0516422366.SGD","LU1226287529.USD","SG9999002463.SGD","LU2125154935.USD","LU0314109678.HKD","LU1226288253.USD","LU1201861249.SGD","LU1242518931.SGD","LU1668664300.SGD","LU0359201885.HKD","LU0823426480.USD","LU0856984785.SGD","LU1807302812.USD","LU1226287792.SGD","LU1794554557.SGD","LU0417516902.SGD","BK1589","LU0648001328.SGD","LGHT","LU0181495838.USD","SG9999002562.SGD","HK0000165453.HKD","IEIH","IE00B5MMRT66.SGD","LU0320764599.SGD","LU0051755006.USD","LU0128522744.USD","LU0326950275.SGD","PTH","FTXO","MEDX","BK1610","IE00B0JY6N72.USD","GDOC","LU1188198961.HKD","01093","LU2039709279.SGD","LU0456846285.SGD","09996","BK4566","LU0708995153.HKD","LU0067412154.USD","LU2462157665.USD","LU1152091168.USD","LU0348825331.USD","LU0348827113.USD","C","LU0348735423.USD","LU0516422952.EUR","LU1366192091.USD","LU0170899867.USD","LU0203347892.USD","LU1023057109.AUD","LU0540923850.HKD","06990","LU0140636845.USD","LU0320764243.SGD","LU0501845795.SGD","LU2097828805.USD","LU2242644610.SGD","LU1244550221.USD","BK1191","IE00BZ08YS42.EUR","LU0039217434.USD","LU1951186391.HKD","SG9999004220.SGD","LNGR","LU0203345920.USD","HART","02269","LU1506573853.SGD","LU2097828474.EUR","LU1162221912.USD","TFNS","BK4588","LU0502904849.HKD","LU1720050803.USD","LU2488822045.USD","LU0417516738.SGD","LU0708995583.HKD","KURE","LU1244550494.USD","LU2360032135.SGD","LU2456880835.USD","LU0516422440.USD","LU1960683339.HKD","LU1993786604.SGD","BK4585","LU0455707207.USD","BK1574","LU0043850808.USD","LU0128526141.USD","LU0607220059.USD","BK4534","LU1226288170.HKD","159883","LU2097828631.EUR","LU0477156953.USD","BK1515","LU0359201612.USD","LU0130102774.USD","LU0072913022.USD","LU0128525689.USD","LU0456827905.SGD","LU1880383366.USD","LU2236285917.USD","RSPH","01276","LU1969619763.USD","LU2097828714.EUR","IE00BSNM7G36.USD","LU3063872942.SGD","01801","LU2328871848.SGD","LU0463099449.HKD","03347","LU2417539215.USD","LU0052756011.USD","BK4207","LU0072461881.USD","LU0634319403.HKD","LU0979878070.USD","IE00BZ08YR35.GBP","IE00B031HY20.USD","LU1008478684.HKD","LU1074936037.SGD","LU1328277881.USD","LU0561508036.HKD","LU0106831901.USD","LU0307460666.USD","LU0314106906.USD","MDEV","IE0008369823.USD","LU0516423174.USD","LU0052750758.USD","LU0310800965.SGD","LU0130517989.USD","LU0327786744.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132658334","title":"Movement Alert｜HENGRUI PHARMA Rises 3.11% in Regular Trading, Buyback Launched and Employee Stock Plan Unveiled Amid BlackRock Accumulation","url":"https://stock-news.laohu8.com/highlight/detail?id=1132658334","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132658334?lang=en_us&edition=fundamental","pubTime":"2026-09-21 09:48","pubTimestamp":1789955285,"startTime":"0","endTime":"0","summary":"On September 21, HENGRUI PHARMA rose 3.11% in regular trading to HKD 47.68, with turnover of HKD 74.67 million. The rally follows a cluster of positive catalysts disclosed late last week.On September...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"HENGRUI PHARMA Rises on Buyback and Employee Stock Plan","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173720732","title":"HENGRUI PHARMA: BlackRock, Inc. Disposes, Long Position Falls to 6.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=1173720732","media":"HK Disclosure","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173720732?lang=en_us&edition=fundamental","pubTime":"2026-09-18 17:43","pubTimestamp":1789724583,"startTime":"0","endTime":"0","summary":"On September 15, 2026, BlackRock, Inc. disposed of 1.92 million H shares of HENGRUI PHARMA (01276) off-exchange, as it no longer held a security interest in the shares; the transaction involved...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141777633","title":"Hong Kong Stock Market Update | Hengrui Pharma Surges Nearly 4% on First A-Share Buyback as Analysts Eye Growth in Non-Oncology Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=1141777633","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141777633?lang=en_us&edition=fundamental","pubTime":"2026-09-18 10:20","pubTimestamp":1789698017,"startTime":"0","endTime":"0","summary":"HENGRUI PHARMA (01276) climbed nearly 4% in Hong Kong trading, with shares last up 3.2% at HK$45.80, on turnover of HK$59.53 million.The move follows the company's announcement that it spent RMB...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1255011170.USD","LU0405327494.USD","LU2328871848.SGD","02846","LU2488822045.USD","LU1997244956.HKD","LU0405327148.USD","BK1147","BK1191","LU2097828631.EUR","83130","LU0359202008.SGD","KCAI","VXUS","159982","LU2580892862.HKD","BK4585","LU1064131003.USD","600276","02827","LU1064130708.USD","LU1146622755.USD","LU2495084118.USD","LU2543165471.USD","BK0012","BK0239","LU1023057109.AUD","03130","BK0028","BK0183","LU0359201612.USD","LU2097828557.USD","399300","LU2097828805.USD","BK0188","82846","01276","LU2148510915.USD","LU1781817850.SGD","LU2097828474.EUR","LU1997245094.SGD","LU0359201885.HKD","LU1969619763.USD","BK4588","BK0060","83188","LU1328615791.USD","LU2289578879.USD","LU2580892789.USD","LU1820825898.SGD","LU2097828714.EUR","BK0196","03188","LU1997245177.USD","LU1580142542.USD","07233","LU1655091616.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198866464","title":"Movement Alert｜HENGRUI PHARMA Rises 3.78% in Regular Trading, First A-Share Buyback Executed as BlackRock Raises Stake to 7.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=1198866464","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198866464?lang=en_us&edition=fundamental","pubTime":"2026-09-18 09:59","pubTimestamp":1789696756,"startTime":"0","endTime":"0","summary":"On September 18, HENGRUI PHARMA rose 3.78% in regular trading, trading at HKD 46.02/share, with turnover of HKD 47.53 million.On the news front, the company disclosed on September 17 that it...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Hengrui Pharma Rises as First Buyback Done, BlackRock Ups Stake","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668996838","title":"Blackrock's Long Position in H-Shares of Jiangsu Hengrui Pharmaceuticals Increases to 7.68% on Sept 14, HKEX Filing Shows","url":"https://stock-news.laohu8.com/highlight/detail?id=2668996838","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668996838?lang=en_us&edition=fundamental","pubTime":"2026-09-17 23:50","pubTimestamp":1789660240,"startTime":"0","endTime":"0","summary":"BRIEF-Blackrock's Long Position In H-Shares Of Jiangsu Hengrui Pharmaceuticals Increases To 7.68% On Sept 14, HKEX Filing ShowsSept 17 (Reuters)-HKEX:BLACKROCK'S LONG POSITION IN H-SHARES OF JIANGSU HENGRUI PHARMACEUTICALS INCREASES TO 7.68% ON SEPT 14Further company coverage:1276.HK","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nFWN45909J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2097828631.EUR","LU0405327494.USD","LU1064130708.USD","LU1969619763.USD","LU2328871848.SGD","LU1146622755.USD","LU2148510915.USD","BK0183","LU1997245094.SGD","BK0239","LU1655091616.SGD","LU2097828557.USD","LU1328615791.USD","01276","LU1781817850.SGD","BK0028","LU1064131003.USD","LU2097828474.EUR","LU1820825898.SGD","LU1023057109.AUD","LU1997245177.USD","BK1191","BK0196","LU0405327148.USD","BK0188","LU1580142542.USD","LU0359201612.USD","BK0060","LU2289578879.USD","LU2488822045.USD","LU1997244956.HKD","LU1255011170.USD","LU2495084118.USD","LU2097828714.EUR","LU2580892789.USD","LU2543165471.USD","BK0012","LU0359201885.HKD","LU2097828805.USD","LU2580892862.HKD","LU0359202008.SGD","600276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150135700","title":"Hengrui Pharma Repurchases 335,000 A-Shares for ESOP at RMB 43.29 Each, Equal to 0.005% of Issued Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=1150135700","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150135700?lang=en_us&edition=fundamental","pubTime":"2026-09-17 19:43","pubTimestamp":1789645419,"startTime":"0","endTime":"0","summary":"On 17 September 2026, Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma) executed an on-market buy-back of 335,000 A-shares on the Shanghai Stock Exchange to support its A-Share Employee...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148606058","title":"Jiangsu Hengrui Pharmaceuticals Completes Initial Share Repurchase, Investing 14.5 Million Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=1148606058","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148606058?lang=en_us&edition=fundamental","pubTime":"2026-09-17 17:24","pubTimestamp":1789637056,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (600276.SH) has announced its first buyback of A-shares, executed through centralized bidding transactions on September 17, 2026.During this transaction, the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2097828631.EUR","LU2495084118.USD","LU1997244956.HKD","600276","LU0405327494.USD","BK0012","BK1191","LU1969619763.USD","LU1997245177.USD","LU2328871848.SGD","LU1023057109.AUD","LU2580892862.HKD","BK0028","LU0359201612.USD","BK0188","BK0239","LU1328615791.USD","01276","LU2097828557.USD","LU2289578879.USD","LU1146622755.USD","BK0060","LU0359201885.HKD","LU1655091616.SGD","LU1820825898.SGD","LU2097828805.USD","LU2097828474.EUR","LU2488822045.USD","BK0196","LU2097828714.EUR","LU2580892789.USD","LU1580142542.USD","LU1997245094.SGD","LU1781817850.SGD","LU2148510915.USD","LU1255011170.USD","LU0359202008.SGD","BK0183","LU2543165471.USD","LU1064130708.USD","LU0405327148.USD","LU1064131003.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148962826","title":"HENGRUI PHARMA: BlackRock, Inc. Acquires Shares, Long Position Rises to 7.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=1148962826","media":"HK Disclosure","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148962826?lang=en_us&edition=fundamental","pubTime":"2026-09-17 17:14","pubTimestamp":1789636453,"startTime":"0","endTime":"0","summary":"On September 14, 2026, BlackRock, Inc. acquired 2.63 million H shares of HENGRUI PHARMA (01276) by way of taking a security interest in shares off-exchange, with consideration being non-cash assets....","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177370867","title":"Hong Kong Stock Market Update: Hengrui Pharma Surges Nearly 4% in Late Trading Following Dual Clinical Trial Approvals","url":"https://stock-news.laohu8.com/highlight/detail?id=1177370867","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177370867?lang=en_us&edition=fundamental","pubTime":"2026-09-16 15:52","pubTimestamp":1789545137,"startTime":"0","endTime":"0","summary":"HENGRUI PHARMA (01276) saw its shares climb nearly 4% during the final stretch of Thursday's trading session, buoyed by regulatory approvals for two distinct clinical programs targeting separate...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2097828557.USD","LU2097828631.EUR","MDTX","PSYK","BK4585","LU0359202008.SGD","LU0405327494.USD","IBBJ","LU2289578879.USD","LU2148510915.USD","LU2580892789.USD","LU1064131003.USD","LU2097828714.EUR","LU0405327148.USD","LU1064130708.USD","BK0012","LU2097828805.USD","LU2543165471.USD","LU1997244956.HKD","BK0188","BK1191","LU0359201885.HKD","LU1655091616.SGD","LU1997245177.USD","LU2097828474.EUR","LU1146622755.USD","LU2488822045.USD","VXUS","LU1820825898.SGD","LU2495084118.USD","LU2580892862.HKD","BK4588","LU1997245094.SGD","BK0028","BK0060","LU0359201612.USD","LU1781817850.SGD","LU1969619763.USD","LU2328871848.SGD","LU1255011170.USD","BMED","BK0183","BK0196","BK0239","LU1023057109.AUD","01276","LU1580142542.USD","600276","LU1328615791.USD","KCAI","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667603734","title":"China's Jiangsu Hengrui Climbs on Clinical Trial Approval for Stroke Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2667603734","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667603734?lang=en_us&edition=fundamental","pubTime":"2026-09-16 15:38","pubTimestamp":1789544325,"startTime":"0","endTime":"0","summary":"BUZZ-China's Jiangsu Hengrui climbs on clinical trial approval for stroke drug** Hong Kong shares of Jiangsu Hengrui Pharmaceuticals1276.HKclimb 3.5% to HK$45.34, on course for the biggest one-day pct","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nL1N45806E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1655091616.SGD","LU0405327148.USD","LU2328871848.SGD","600276","LU0359201612.USD","LU2580892862.HKD","BK0196","LU1146622755.USD","LU1997244956.HKD","LU2495084118.USD","LU2543165471.USD","BK0012","LU2097828714.EUR","LU1023057109.AUD","BK0060","LU2097828631.EUR","BK0028","LU2097828557.USD","LU1820825898.SGD","LU1064131003.USD","LU1997245094.SGD","01276","LU0359201885.HKD","LU1255011170.USD","BK1191","LU1580142542.USD","LU1064130708.USD","LU0405327494.USD","LU2148510915.USD","LU2097828474.EUR","BK0183","BK0239","LU2488822045.USD","LU1997245177.USD","LU1969619763.USD","LU2580892789.USD","LU2289578879.USD","LU2097828805.USD","LU1781817850.SGD","LU0359202008.SGD","LU1328615791.USD","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667679529","title":"Hengrui Pharmaceuticals' Unit Gets Nod to Trial Recaticimab Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2667679529","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667679529?lang=en_us&edition=fundamental","pubTime":"2026-09-16 10:29","pubTimestamp":1789525750,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals  unit, Guangdong Hengrui Pharmaceutical, received approval from China's National Medical Products Administration for the clinical trial of recaticimab injection, according to a Shanghai bourse filing on Wednesday.The drug is used to treat adult patients with intracranial atherosclerotic stenosis to reduce the risk of recurrent stroke.The pharmaceutical company invested 422.2 million yuan into the research and development of the drug.The company's Hong Kong shares rose 2% during the morning trade.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1255011170.USD","600276","BK0183","LU2289578879.USD","LU2097828557.USD","LU2097828714.EUR","LU1580142542.USD","LU2543165471.USD","BK0060","LU0359201612.USD","BK0188","LU1328615791.USD","01276","LU1064130708.USD","LU2148510915.USD","BK0028","LU2097828474.EUR","LU2495084118.USD","LU0405327494.USD","LU1023057109.AUD","LU1146622755.USD","LU1820825898.SGD","LU1997245177.USD","LU1064131003.USD","LU2580892862.HKD","LU1997245094.SGD","LU2097828805.USD","LU2488822045.USD","LU2328871848.SGD","LU1781817850.SGD","BK0196","LU1997244956.HKD","BK0012","LU0405327148.USD","LU2580892789.USD","LU1969619763.USD","BK1191","LU0359201885.HKD","LU2097828631.EUR","LU1655091616.SGD","LU0359202008.SGD","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}